Drug profile · INN
topotecan
HYCAMTIN
topotecan (HYCAMTIN) is a dna topoisomerase i, mitochondrial inhibitor. Associated with Accord Healthcare Pty..
EMA: approved TGA: approved NMPA: clinical trials Antineoplastic and immunomodulating agents (L01) L01CE01
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — topotecan
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
topotecan (HYCAMTIN) is a dna topoisomerase i, mitochondrial inhibitor. Associated with Accord Healthcare Pty..
Key facts
INN topotecan
Brand HYCAMTIN
Mechanism DNA topoisomerase I, mitochondrial inhibitor
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01CE01
Originator Accord Healthcare Pty.
Mechanism of action
DNA topoisomerase I, mitochondrial inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is topotecan?
topotecan (HYCAMTIN) is a dna topoisomerase i, mitochondrial inhibitor. Associated with Accord Healthcare Pty..
What is the brand name for topotecan?
HYCAMTIN is a marketed brand name for topotecan. Check FDA Drugs@FDA for the current US label holder and prescribing information.